Flagship Pioneering and Pfizer partner to accelerate development of innovative medicines targeting unmet needs

Flagship Pioneering, Inc. and Pfizer Inc. (NYSE: PFE) today announced the companies have partnered to create a new pipeline of innovative medicines. Under the terms of the novel agreement, Flagship and Pfizer will each invest $50M upfront to explore opportunities to develop 10 single-asset programs by leveraging Flagship's ecosystem of more than 40 human health companies and multiple biotechnology platforms.

from Breaking World Pharma News https://ift.tt/8x5H9hL